Study of the Sex Differences in Inflammatory Diseases in Children
NCT ID: NCT04815811
Last Updated: 2021-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
160 participants
INTERVENTIONAL
2019-08-17
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this work is to evaluate the role of the X chromosome in the sex differences in inflammatory diseases in children. In order to discriminate more precisely the role of the X chromosome relatively to the sex steroids in the sex-specific inflammatory response, some innate immune functions related to X-linked genes will be evaluated in whole blood from prepubertal children of both sexes, suffering from acute inflammatory processes such as pyelonephritis caused by Escherichia coli, pneumonia with pleural effusion caused by Streptococcus pneumoniae or sepsis
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MultiOrgan Inflammatory Syndromes COVID-19 Related Study
NCT04811456
COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children
NCT05334134
Data Collection Study of Pediatric and Adolescent Gynecology Conditions
NCT04717349
Inflammatory Biomarkers of Pediatric Pulmonary Hypertension
NCT03581695
Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences
NCT04741412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On the contrary, worse prognosis for women is observed in chronic inflammatory diseases such as asthma or cystic fibrosis (8-10,12,13,29).
Sex-depended inflammatory response was attributed to the influence of sex hormones on the immune system. (2,15-18). However recent studies revealed differences in the clinical outcome but also in inflammatory markers between boys and girls suffering from acute and chronic inflammatory diseases (19-23). Sex hormone levels in prepubertal children are particularly low and insufficient to explain the gender differences observed in inflammatory conditions from neonates to the elderly, suggesting the contribution of another mechanism, such as the influence of genes situated on the sex chromosomes and involved in the inflammatory response.
The aim of this work is to identify the potential X-linked mechanisms responsible for some of the differences between boys and girls in the inflammatory response, making the girls more at risk of developing complications in chronic inflammatory diseases and the boys more at risk of lethal complications in severe acute inflammatory diseases like sepsis. Several genes coding for innate immunity components are linked to the X chromosome such as diapedesis molecule CD99 or TLR pathway proteins genes. (30-33). X chromosome is also highly enriched in genes encoding micro RNAs (miRNAs) involved in the post-transcriptional regulation of gene expression which play a critical role in immune inflammatory response (34-36).
Thus, in order to discriminate more precisely the role of the X chromosome relatively to the sex steroids in the sex-specific inflammatory response, some innate immune functions related to X-linked genes will be evaluated in whole blood from prepubertal children of both sexes, suffering from acute inflammatory processes such as pyelonephritis caused by Escherichia coli, pneumonia with pleural effusion caused by Streptococcus pneumoniae or sepsis. We will also study the correlations between inflammatory and clinical markers of the disease activity to identify prognosis indicators depending on the sex. Additionally, to delineate microbiome contribution, we will study the gut microbiota in stool samples obtained from the recruited patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children suffering from acute inflammatory processes.
The study population will consist of male and female children, aged from 6 months to 7 years old, admitted to the hospital for one of the three following types of acute inflammatory processes:
* Urinary tract infection caused by Escherichia coli
* Pneumonia with pleural effusion caused by Streptococcus pneumoniae
* Sepsis
Blood collection
Blood samples collections to evaluation of the potential role of the sex chromosomes in the innate immune response by analyzing inflammatory cytokine production (IL-1β, IL-6, IL-8, IL-10, TNF-α and IFN-α), studying the cell diapedesis receptor CD99 on PMNs, monocytes, and lymphocytes, analyzing the contribution of X-linked genes of the TLR pathways and the influence of X-linked miRNAs.
Stool collection
Fecal sample collection to delineate microbiome contribution, we will study the gut microbiota in faecal samples obtained from the recruited patients.
Control group
Male and female children, aged from 6 months to 7 years old, admitted to the hospital for a scheduled operation for a non-inflammatory pathology.
Blood collection
Blood samples collections to evaluation of the potential role of the sex chromosomes in the innate immune response by analyzing inflammatory cytokine production (IL-1β, IL-6, IL-8, IL-10, TNF-α and IFN-α), studying the cell diapedesis receptor CD99 on PMNs, monocytes, and lymphocytes, analyzing the contribution of X-linked genes of the TLR pathways and the influence of X-linked miRNAs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood collection
Blood samples collections to evaluation of the potential role of the sex chromosomes in the innate immune response by analyzing inflammatory cytokine production (IL-1β, IL-6, IL-8, IL-10, TNF-α and IFN-α), studying the cell diapedesis receptor CD99 on PMNs, monocytes, and lymphocytes, analyzing the contribution of X-linked genes of the TLR pathways and the influence of X-linked miRNAs.
Stool collection
Fecal sample collection to delineate microbiome contribution, we will study the gut microbiota in faecal samples obtained from the recruited patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject hospitalized either for:
(1) Urinary tract infection caused by Escherichia Coli, with:
* Temperature ≥ to 38,5°C
* Urinalysis
* Leukocyte esterase +
* AND/OR Nitrites +
* AND/OR pyuria (≥ 100WBC/mm³)
* AND/OR bacteriuria.
* Urinalysis
* Clean catch voided urine: \> 10\^4 Escherichia Coli colony form unit (CFU)/mm (urine collection method for children \>3 years old or toilet trained children or by stimulation for children \<3 years old)
* Transurethral bladder catheterisation: \> 10\^4 Escherichia Coli colony form unit (CFU)/mm³ (urine collection method for children \<3 years old).
* Suprapubic aspiration: \> 1 Escherichia Coli colony form unit (CFU)/mm³ (urine collection method for children \<3 years old).
(2) Pneumonia with pleural effusion with :
* Temperature ≥ 38,5°C
* Chest radiography/ultrasound: Pleural effusion
* Streptococcus pneumoniae identified on blood or pleural fluid culture or by PCR
(3) Sepsis with:
* Documented or suspected infection
* Temperature \< 36° or \> 38.3°C
* Heart rhythm:
* 2 SD above normal for age
* 6-23 months: \>180/min
* 24-71 months: \>140/min
* 72-84 months: \>130/min
* Respiratory Rate:
* 6-23 months: \>35/min
* 24 - 71 months: \>30/min
* 72-84 months: \>20/min
* WBC:
* 6-23 months: \>17500/µL or \<5000/µL
* 24-71 months: \>15500/µL or \<6000/µL
* 72-84 months: \>13500/µL or \<4500/µL
* and/or CRP (blood) \> 2SD above normal
* And at least two of the following:
* PaO2/FiO2 \<300
* Proven need for \>50% FiO2 to maintain saturation ≥ 92%
* Need for mechanical ventilation
* Glasgow score \< 11
* Urine output \< 0,5mL/kg/h for at least 2h
* Creatinine:
* 6-11 months: \>0,4mg/dL
* 12-23 months: \>0,5mg/dL
* 24-59 months: \>0,8mg/dL
* 60-84 months: \>1mg/dL
* Or creatinine increase more than 0,5 mg/dL
* Platelet count \<100000/mL
* Bilirubin \>2 mg/dL
* Mean arterial pressure (MAP)
* 6-11 months: \<55 mmHg
* 12 -23 months: \<60 mmHg
* 24-59 months: \<62 mmHg
* 60-84 months: \<65 mmHg
* SBP less than two SD below normal for age
* Prolonged capillary refill: \> 5 sec
* Male (XY) and female (XX) aged from 6 months to 7 years old.
* Scheduled surgical intervention for a non-infectious pathology.
Exclusion Criteria
* Congenital or acquired immunodeficiency: immunosuppressive drugs, hematopoietic stem cells transplantation, immunoglobulin therapy, extracorporeal membrane oxygenation (ECMO).
* Hemodialysis.
* 48h following cardiac operation of any type.
* Malignant cancer.
* HIV.
6 Months
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Belgium Kid's Fund
UNKNOWN
Queen Fabiola Children's University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandros Popotals, MD
Role: PRINCIPAL_INVESTIGATOR
HUDERF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HUDERF
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. Gender differences in human sepsis. Arch Surg. 1998 Nov;133(11):1200-5. doi: 10.1001/archsurg.133.11.1200.
Angele MK, Pratschke S, Hubbard WJ, Chaudry IH. Gender differences in sepsis: cardiovascular and immunological aspects. Virulence. 2014 Jan 1;5(1):12-9. doi: 10.4161/viru.26982. Epub 2013 Nov 5.
Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 2000 Feb;26(2):167-72. doi: 10.1007/s001340050041.
Schoeneberg C, Kauther MD, Hussmann B, Keitel J, Schmitz D, Lendemans S. Gender-specific differences in severely injured patients between 2002 and 2011: data analysis with matched-pair analysis. Crit Care. 2013 Nov 29;17(6):R277. doi: 10.1186/cc13132.
Moss M, Mannino DM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996). Crit Care Med. 2002 Aug;30(8):1679-85. doi: 10.1097/00003246-200208000-00001.
Carr MJ, Moss E, Waters A, Dean J, Jin L, Coughlan S, Connell J, Hall WW, Hassan J. Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J Clin Microbiol. 2010 Sep;48(9):3288-94. doi: 10.1128/JCM.00434-10. Epub 2010 Jul 21.
McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz). 2011 Jun;59(3):203-13. doi: 10.1007/s00005-011-0124-3. Epub 2011 Mar 26.
Vink NM, Postma DS, Schouten JP, Rosmalen JG, Boezen HM. Gender differences in asthma development and remission during transition through puberty: the TRacking Adolescents' Individual Lives Survey (TRAILS) study. J Allergy Clin Immunol. 2010 Sep;126(3):498-504.e1-6. doi: 10.1016/j.jaci.2010.06.018.
Venn A, Lewis S, Cooper M, Hill J, Britton J. Questionnaire study of effect of sex and age on the prevalence of wheeze and asthma in adolescence. BMJ. 1998 Jun 27;316(7149):1945-6. doi: 10.1136/bmj.316.7149.1945. No abstract available.
Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy. 2008 Nov;63(11):1418-27. doi: 10.1111/j.1398-9995.2008.01880.x.
Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease: the impact of gender. Curr Opin Pulm Med. 2017 Mar;23(2):117-123. doi: 10.1097/MCP.0000000000000353.
Fogarty A, Hubbard R, Britton J. International comparison of median age at death from cystic fibrosis. Chest. 2000 Jun;117(6):1656-60. doi: 10.1378/chest.117.6.1656.
Sweezey NB, Ratjen F. The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol. 2014 Apr;49(4):309-17. doi: 10.1002/ppul.22967. Epub 2013 Dec 11.
Betteridge JD, Armbruster SP, Maydonovitch C, Veerappan GR. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis. 2013 Jun;19(7):1421-7. doi: 10.1097/MIB.0b013e318281334d.
Ahmed SA, Talal N. Sex hormones and the immune system--Part 2. Animal data. Baillieres Clin Rheumatol. 1990 Apr;4(1):13-31. doi: 10.1016/s0950-3579(05)80241-9.
Lahita RG. Sex hormones and the immune system--Part 1. Human data. Baillieres Clin Rheumatol. 1990 Apr;4(1):1-12. doi: 10.1016/s0950-3579(05)80240-7. No abstract available.
Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005 Jul-Aug;11(4):411-23. doi: 10.1093/humupd/dmi008. Epub 2005 Apr 7.
Bosch F, Angele MK, Chaudry IH. Gender differences in trauma, shock and sepsis. Mil Med Res. 2018 Oct 26;5(1):35. doi: 10.1186/s40779-018-0182-5.
Casimir GJ, Heldenbergh F, Hanssens L, Mulier S, Heinrichs C, Lefevre N, Desir J, Corazza F, Duchateau J. Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children. J Inflamm (Lond). 2010 Jun 2;7:28. doi: 10.1186/1476-9255-7-28.
Casimir GJ, Mulier S, Hanssens L, Knoop C, Ferster A, Hofman B, Duchateau J. Chronic inflammatory diseases in children are more severe in girls. Shock. 2010 Jul;34(1):23-6. doi: 10.1097/SHK.0b013e3181ce2c3d.
Casimir GJ, Mulier S, Hanssens L, Zylberberg K, Duchateau J. Gender differences in inflammatory markers in children. Shock. 2010 Mar;33(3):258-62. doi: 10.1097/SHK.0b013e3181b2b36b.
Casimir GJ, Lefevre N, Corazza F, Duchateau J. Sex and inflammation in respiratory diseases: a clinical viewpoint. Biol Sex Differ. 2013 Sep 1;4:16. doi: 10.1186/2042-6410-4-16. eCollection 2013.
Lefevre N, Noyon B, Biarent D, Corazza F, Duchateau J, Casimir G. Sex Differences in Inflammatory Response and Acid-Base Balance in Prepubertal Children with Severe Sepsis. Shock. 2017 Apr;47(4):422-428. doi: 10.1097/SHK.0000000000000773.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003 Apr 17;348(16):1546-54. doi: 10.1056/NEJMoa022139.
Wichmann et al. - 2000 - Incidence and mortality of severe sepsis in surgic.pdf [Internet]. [cited 2019 Feb 27]. Available from: https://link.springer.com/content/pdf/10.1007/s001340050041.pdf
The effect of sex on asthma control from the National Asthma Survey - Journal of Allergy and Clinical Immunology [Internet]. [cited 2019 Feb 27]. Available from: https://www.jacionline.org/article/S0091-6749(08)02373-7/fulltext
Johnston CM, Lovell FL, Leongamornlert DA, Stranger BE, Dermitzakis ET, Ross MT. Large-scale population study of human cell lines indicates that dosage compensation is virtually complete. PLoS Genet. 2008 Jan;4(1):e9. doi: 10.1371/journal.pgen.0040009. Epub 2007 Dec 13.
Lefevre N, Corazza F, Duchateau J, Desir J, Casimir G. Sex differences in inflammatory cytokines and CD99 expression following in vitro lipopolysaccharide stimulation. Shock. 2012 Jul;38(1):37-42. doi: 10.1097/SHK.0b013e3182571e46.
Spolarics Z. The X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infection. Shock. 2007 Jun;27(6):597-604. doi: 10.1097/SHK.0b013e31802e40bd.
Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002 Oct;2(10):725-34. doi: 10.1038/nri910.
O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010 Feb;10(2):111-22. doi: 10.1038/nri2708.
Ceribelli A, Satoh M, Chan EK. MicroRNAs and autoimmunity. Curr Opin Immunol. 2012 Dec;24(6):686-91. doi: 10.1016/j.coi.2012.07.011. Epub 2012 Aug 14.
Dorhoi A, Iannaccone M, Farinacci M, Fae KC, Schreiber J, Moura-Alves P, Nouailles G, Mollenkopf HJ, Oberbeck-Muller D, Jorg S, Heinemann E, Hahnke K, Lowe D, Del Nonno F, Goletti D, Capparelli R, Kaufmann SH. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest. 2013 Nov;123(11):4836-48. doi: 10.1172/JCI67604.
Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, Campos R, Ernst D, Gaur A. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol. 2004 Mar;110(3):252-66. doi: 10.1016/j.clim.2003.11.017.
Kuczynski J, Stombaugh J, Walters WA, Gonzalez A, Caporaso JG, Knight R. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr Protoc Bioinformatics. 2011 Dec;Chapter 10:10.7.1-10.7.20. doi: 10.1002/0471250953.bi1007s36.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P2019/LABO/SepsiX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.